E2-based mRNA vaccine encapsulated in lipid nanoparticles protects pigs against classical swine fever virus

文献类型： 外文期刊

第一作者： Liu, Jingyi

作者： Liu, Jingyi;Xia, Yingju;Chen, Ziyu;Li, Jiaxin;Liu, Yebing;Liu, Jingyi;Tian, Chuanwen;Guo, Weiqiang;Liu, Yingnan;Xie, Zhenhua;Chen, Hongjun;Tian, Chuanwen;Liu, Yingnan;Chen, Hongjun;Guo, Weiqiang;Wen, Jing;Lin, Jinzhong

作者机构：

关键词： mRNA vaccine; CSFV; E2 protein; protective immunity

期刊名称：JOURNAL OF VIROLOGY （ 影响因子：3.8； 五年影响因子：3.9 ）

ISSN： 0022-538X

年卷期： 2025 年

页码：

收录情况： SCI

摘要： Classical swine fever (CSF), caused by the classical swine fever virus (CSFV), remains a significant threat to the global pig industry. Recent advances in mRNA vaccines offered a promising platform for combating CSFV. In this study, we designed and evaluated three lipid nanoparticle (LNP)-encapsulated mRNA vaccine candidates encoding the ectodomain of E2 glycoprotein (E2_EX), E2_EX fused with the transmembrane (TM) region of the PEDV S protein (E2tm), and E2_EX fused with the TM region of the influenza virus HA protein (E2tm-HA). Among these, the E2tm mRNA vaccine induced the most robust antibody responses in pigs. Immunization of piglets with the E2tm mRNA vaccine showed that its immunogenicity was not impaired by maternal antibodies. Comparative analysis of pseudouridine (Psi)-modified (Psi E2tm) and unmodified (E2tm) mRNA vaccines revealed that E2tm induced significantly higher antibodies titers than Psi E2tm. All vaccinated pigs survived the CSFV challenge, with the 150 mu g E2tm dose providing optimal protection, effectively suppressing viremia and preventing viral dissemination to tissues while also resulting in undetectable viral RNA in swab samples. Our findings provide a promising novel mRNA vaccine that could be used as an alternative vaccination strategy against CSFV infection.IMPORTANCEClassical swine fever virus (CSFV) remains a significant threat to the global pig industry. While live attenuated and subunit vaccines are currently in use, there is an urgent need for more effective and safer vaccination strategies. Here, we present a novel mRNA vaccine encoding the CSFV E2 glycoprotein, which provides protective immunity against the CSFV challenge in pigs. Our findings underscore the promising efficacy of this mRNA-based vaccine platform and offer an alternative strategy for CSFV prevention and control.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序